Did your prescriber add Ritalin IR as a booster, or a second long-acting dose?

Both a short-acting methylphenidate booster, often discussed as Ritalin immediate-release, and a second long-acting dose are strategies some clinicians use when one morning long-acting stimulant does not cover the full day, but neither is a universal correct add-on, and this thread cannot say which your prescriber should have chosen. CADDRA duration estimates are approximate: Concerta about 12 hours with an OROS profile, Biphentin about 10 to 12 hours, Foquest about 13 to 16 hours, Vyvanse about 13 to 14 hours, Dexedrine tablets about 4 hours. Individual coverage often differs from the chart. If the change is persistent, distressing, or affecting daily functioning, bring a brief timeline to the prescribing clinician rather than changing the dose independently. Related reading: https://www.fastreat.com/en/blogs/adhd-medication References: https://www.caddra.ca/wp-content/uploads/CADDRA_ADHD-Medication-Chart_May2026.pdf https://www.camh.ca/en/professionals/treating-conditions-and-disorders/adult-adhd/adult-adhd---treatment/adult-adhd---pharmacotherapy https://www.caddra.ca/wp-content/uploads/Canadian-ADHD-Practice-Guidelines-4.1-January-6-2021.pdf

I work late, so they used a second long-acting dose instead of Ritalin. Evenings were more usable, and bedtime got harder. I cannot tell you which strategy is smarter. I only know I was not supposed to invent a late tablet on my own. This is just my schedule and my trade-off, not a comparison anyone else should copy from my bottle.

Concerta faded for me mid-afternoon, and the add-on was Ritalin, not a second long-acting capsule. Some days the booster saved the end of work. If I took it late I did not sleep. I have no idea whether another XR would have been cleaner. I did not add the booster myself. This is only my crash and my bottle, not a template.